NM_000059.4(BRCA2):c.532A>G (p.Lys178Glu) AND Hereditary breast ovarian cancer syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Mar 4, 2020
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001315799.6
Allele description [Variation Report for NM_000059.4(BRCA2):c.532A>G (p.Lys178Glu)]
NM_000059.4(BRCA2):c.532A>G (p.Lys178Glu)
Condition(s)
- Name:
- Hereditary breast ovarian cancer syndrome
- Synonyms:
- Hereditary breast and ovarian cancer syndrome; Hereditary breast and ovarian cancer; Hereditary breast and ovarian cancer syndrome (HBOC); See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0003582; MeSH: D061325; MedGen: C0677776; Orphanet: 145
-
"115-53-7"[CompleteSynonym] (1)
PubChem Compound
-
Homo sapiens cDNA FLJ36984 fis, clone BRACE2006540
Homo sapiens cDNA FLJ36984 fis, clone BRACE2006540gi|21753337|dbj|AK094303.1|Nucleotide
-
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent c...
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomibAccession: GDS5826GEO DataSets
-
Related DataSets for GEO Profiles (Select 131933115) (1)
GEO DataSets
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 1, 2024